Plasma concentration monitoring of aminoglycosides.
D000617:Aminoglycosides / Q000009:adverse effects / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000097:blood*; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents